Alexion Pharmaceuticals, Inc. (ALXN) Tops Q4 EPS by 4c; Issues Strong Outlook
Tweet Send to a Friend
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported Q4 EPS of $0.87, $0.04 better than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
